{"url_path":"/sec/brns/8-k/2026-05-21/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1828185/0001104659-26-064761-index.html","accession_number":"0001104659-26-064761","cik":"0001828185","ticker":"BRNS","issuer_name":"Barinthus Biotherapeutics plc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1828185/0001104659-26-064761-index.html","primary_entity_key":"0001828185","primary_entity_name":"Barinthus Biotherapeutics plc."},"word_count":435,"has_tables":true,"body_markdown":"false\n0001828185\n00-0000000\n\n0001828185\n\n2026-05-20\n2026-05-20\n\n0001828185\n\nVACC:AmericanDepositarySharesMember\n\n2026-05-20\n2026-05-20\n\n0001828185\n\nus-gaap:CommonStockMember\n\n2026-05-20\n2026-05-20\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n****\n\n****\n\n \n\n** **\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n** **\n\n**FORM 8-K**\n\n** **\n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or 15(d)**\n\n**of the Securities Exchange Act of 1934**\n\n \n\n**Date\nof Report (Date of earliest event reported):****May 20, 2026**\n\n** **\n\n**BARINTHUS BIOTHERAPEUTICS PLC**\n\n**(Exact name of registrant as specified in its\ncharter)**\n\n** **\n\n**England and Wales**\n**001-40367**\n**Not Applicable**\n\n**(State or other jurisdiction**\n\n**of incorporation)**\n\n**(Commission**\n\n**File Number)**\n\n**(I.R.S. Employer**\n\n**Identification No.)**\n\n** **\n\n**c/o Barinthus Biotherapeutics plc**\n\n**20400 Century Boulevard, Suite 210**\n\n**Germantown,\nMD 20874**\n\n**United States of America**\n\n**(Address of principal executive offices, including\nzip code)**\n\n \n\n**(443) 917-0966**\n\n**(Registrant’s telephone number, including\narea code)**\n\n \n\n**Not Applicable** \n\n**(Former name or former address, if changed since\nlast report)**\n\n** **\n\nCheck the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n** **\n\n¨\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n** **\n\n¨\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n** **\n\n¨\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n** **\n\n¨\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n** **\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n** **\n\nTitle of each class\nTrade Symbol(s)\nName of each exchange on which\n\nregistered\n\nAmerican Depositary Shares\nBRNS\nThe Nasdaq Global Market\n\nOrdinary shares, nominal value £0.000025 per share*\n \n \n\n \n\nIndicate by check mark whether the registrant is an emerging growth\ncompany as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange\nAct of 1934 (§ 240.12b-2 of this chapter).\n\n \n\nEmerging growth company  x\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act.  ¨\n\n \n\n*\nAmerican Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) ordinary\nshare. Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Global Market. The American\nDepositary Shares represent the right to receive ordinary shares and are being registered under the Securities Act of 1933, as amended,\npursuant to a separate Registration Statement on Form F-6. Accordingly, the American Depositary Shares are exempt from the operation\nof Section 12(a) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12a-8.\n\n \n\n \n\n00-0000000"}